Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin Prophylaxis Duration in Laryngeal Surgery
NCT00467948Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2004
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of cefazolin in surgical site infection (SSI), sponsored by Tehran University of Medical Sciences. Started Jun 2004; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT00467948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467948.